BCL2 and cancer: It has been shown that oncogenes and/or tumour suppressor genes may be disrupted dramatically by modulating miRNAs in human cancers; for example, miR-16-1 and miR-15a negatively regulate BCL2 production and miR-17-92 cooperates with c-Myc to stimulate proliferation [95].